Search results for “site:ncbi.nlm.nih.gov”
Page 24 of about
437 results
n
ncbi.nlm.nih.gov
pubmed › 32417304
COVID-19 first appeared in Wuhan, Hubei Province, China, in December 2019. Thought to be of zoonotic origin, it has been named SARS-CoV-2 (COVID-19) and has spread rapidly. As of April 20, 2020, there have been >2.4 million cases recorded worldwide. The inflammatory process, cytokine storm, and l …
n
ncbi.nlm.nih.gov
pubmed › 32418199
Angiotensin-converting enzyme 2 (ACE2) has been established as the functional host receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for the current devastating worldwide pandemic of...
n
ncbi.nlm.nih.gov
pubmed › 32437830
Liver enzyme abnormalities are common in patients with coronavirus disease 2019 (COVID-19). We reported the clinical characteristics and liver pathological manifestations of COVID-19 patients with elevated liver enzymes. Our findings...
n
ncbi.nlm.nih.gov
pubmed › 32441303
Relative to controls, COVID-19 placentas show increased prevalence of decidual arteriopathy and other features of MVM, a pattern of placental injury reflecting abnormalities in oxygenation within the intervillous space associated with...
n
ncbi.nlm.nih.gov
pubmed › 32445440
Our data show that remdesivir was superior to placebo in shortening the time to recovery in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection. (Funded by the National Institute of Allergy and...
n
ncbi.nlm.nih.gov
pubmed › 32446324
Detection of SARS-CoV-2 in human breastmilk
n
ncbi.nlm.nih.gov
pubmed › 32447630
A pandemic due to novel coronavirus arose in mid-December 2019 in Wuhan, China, and in 3 months' time swept the world. The disease has been referred to as COVID-19, and the causative agent has been labelled SARS-CoV-2 due to its genetic...
n
ncbi.nlm.nih.gov
pubmed › 32450787
Patients with novel coronavirus disease 2019 (COVID-19) experience various degrees of liver function abnormalities. Liver injury requires extensive work-up and continuous surveillance and can be multifactorial and heterogeneous in nature....
n
ncbi.nlm.nih.gov
pubmed › 32458198
Acute transverse myelitis after COVID-19 pneumonia
n
ncbi.nlm.nih.gov
pubmed › 32471707
This unprecedented crisis may interact with certain dimensions of the suicidal process. However, it is time to innovate. Several suicide prevention tools all have their place in new modes of care and should be tested on a large scale.
Try “site:ncbi.nlm.nih.gov” on:
Marginalia ·
Mojeek ·
Wiby ·
DuckDuckGo ·
Bing ·
Google ·
Wikipedia ·
Internet Archive